Improved technologies for high-throughput genotyping and the establishment of well-defined cohorts prompted hope that polymorphisms would be discovered that define a patients' risk of respiratory disease or aid in diagnosis. Genetic pitfalls encountered in this quest include genotyping errors, ethnic differences and linkage dysequilibrium. Differences in the definition of the disease phenotype also create discrepancies, so immunogenetic testing has not yet reached the clinic. However, associations between a polymorphism and a disease phenotype place the gene or one in linkage dysequilibrium on the path to the disease. Here we review studies of immune-related genes that are illuminating the immunopathogenesis of community-acquired pneumonia and mycobacterial infections.
Introduction
There is no question that genetic differences have an impact on the risk of developing or dying from infection. The familial risk of death from infection may be greater than that from cancer or cardiovascular disease [Sorensen et al. 1988 ]. This fits the reality that infectious diseases were the largest cause of death during our evolution. Variation in individual outcomes following exposure to a respiratory pathogen and differential susceptibility to pulmonary infections reflect the genetic diversity in immune responses that have evolved in response to infectious challenges [Burgner et al. 2006 ]. Indeed, immune-related genes are numerous and diverse [Murphy, 1993] .
While pharmacogenetic studies have advanced many fields (notably oncology), diverse and extensive explorations of genetic influences on infectious diseases have provided no real clinical applications. Rare Mendelian immunologic deficiencies affect immunoglobulins, complement components, rearrangement of the T-cell receptor, a few cytokines and some cytokine receptors producing characteristic and severe phenotypes [Quintana-Murci et al. 2007 ]. However, the complexity and redundancy in immunological pathways allows multiple genetic influences to affect outcome, depending on the pathogen and environmental factors. Moreover, most genetic variations are single nucleotide polymorphisms (SNP) which do not abrogate production of the protein or generate a dysfunctional protein.
Rather they lie in putative regulatory areas and affect the rate of transcription or the stability of the mRNA product, creating a more subtle phenotype.
Common limitations with genetic studies in pulmonary infection Several problems are common in gene association studies and limit interpretation or application of the findings. These need to be addressed to minimize spurious associations.
(1) Linkage dysequilibrium (LD) refers to the coinheritance of polymorphisms across segments of DNA that can encompass many genes (Figure 1) , creating conserved haplotypes. Without detailed mapping of the DNA region around the polymorphism(s), observed associations may actually reflect a coinherited polymorphism in the same gene or one close by. Examples are evident in our discussion of tumour necrosis factor (TNF) and lymphotoxin alpha (LTA). (2) Ethnic populations have different frequencies of polymorphisms and different haplotypes. Some haplotypes are restricted to specific populations. This may reflect a recent polymorphism or survival of a particular founding population [Valente et al. 2009 ]. It is critical that cases and controls are drawn from the same racial (e.g. genetic) background.
(3) Replication of results may be hampered by demographic differences in the populations studied. Age (paediatric versus adult versus elderly), comorbidities, severity of illness and differences in the pathogen mix can influence which genes have an impact upon outcome. (4) Even a small number of genotyping errors can alter the results of a study, especially when the number of outcomes is relatively small. Many studies do not report quality assurance protocols to ensure that genotyping errors were minimized. Quality assurance protocols should address analytical discrepancies due to small study cohorts, nonuniform experimental and/or statistical methods and poor control of confounding methods. Deviations from Hardy Weinberg equilibrium are often ignored, but may flag genotyping errors.
It is worthwhile to define the criteria that must be satisfied to consider a polymorphism contributes directly to genetic risk. These include:
(a) extensive validation of the association in more than one independent cohort representative of different ethnic populations across the globe; (b) evidence of altered production or function of the protein product of the gene carrying the polymorphism; (c) demonstration that the association does not reflect LD with other candidates. New chromosomal segment after recombination Figure 1 . Polymorphisms A, B and C are usually inherited together as even though they may be in separate genes, they are close enough that recombination rarely occurs between them. In contrast polymorphisms D and E are not coinherited due to recombination. In this example investigators may think they are studying the effects of polymorphism A, when in fact their results may be due to the influence of polymorphisms B or C (but not D or E). When coinheritance occurs more commonly than by chance, the polymorphisms are said to be in linkage dysequilibrium.
no underlying health problems can die from pneumonia. Although old age is a risk factor, more than half of deaths from bacteremic pneumococcal pneumonia occur between 18 and 65 years of age [Feikin et al. 2000 ].
Understanding the effect of variant SNP or haplotype on the amount or function of an encoded protein should illuminate its role in the pathogenesis of CAP. Genetic studies may identify aspects of pathophysiology that are not apparent from traditional laboratory studies [Wunderink and Waterer, 2004] .
Many genes have been studied to identify polymorphisms that affect CAP. While even more have been studied in relation to sepsis, the findings cannot be generalized to pneumonia [Russell et al. 2010 ]. Hence, we limit this review to pneumonia. Only mannose-binding lectin (MBL, encoded by the MBL2 gene) and the IgG 2 Fc gamma receptor II a (FcgRIIa also known as CD32, encoded by the FCGR2 gene) currently meet the criteria established above. We discuss these first. Other polymorphisms are grouped by their place in the inflammatory response (see Table 1 ) and discussed in the review of candidate SNPs section.
MBL is a soluble pattern-recognition molecule that binds micro-organisms and has independent ability to activate the complement system. Several polymorphisms within the gene or in the promoter region influence serum concentrations of MBL and consequently affect the outcome of many types of infections [Garred et al. 2006 Three major classes of immunoglobulin G receptors are expressed on human leukocytes: FcgRI (CD64); FcgRII (CD32); and FcgRIII (CD16). Human FcgRIIa (encoded by FCGR2) has two codominantly expressed isoforms which differ by one amino acid arginine (R, Arg) to histidine (H, His) at position 131 which results from a single base substitution. FcgRIIa-R131 protein (encoded by C allele at FCGR2 Arg131His (rs1801274)) is associated with decreased binding of human IgG 2 and IgG 3 compared with FcgRIIa-H131 protein (encoded by T allele) [Parren et al. 1992] . Two studies suggest that homozygosity for the C allele at FCGR2 Arg131His is a risk factor for bacteremic pneumococcal pneumonia in paediatric patients [Yuan et al. 2008; Yuan and Sullivan, 2005] , while another found a positive association with mortality and length of hospital stay [Endeman et al. 2009 ]. These results were not replicated by another study [Moens et al. 2006b ], but this had only 55 patients.
LD with polymorphisms in IL10 in the same region of chromosome 1 complicates the assessment of the FCGR2 Arg131His polymorphism [van der Pol et al. 2001] . No published study of pneumonia has performed haplotype mapping across the entire FCGR2 and IL10 region so critical polymorphisms have not been identified, although the biological basis for a role for FcgRIIa is relatively sound. FCGR2 genotypes also exhibit ethnic variation. Asian populations (Chinese, Japanese and Vietnamese) have a lower frequency of homozygous C allele at FCGR2 Arg131His, and a high frequency for homozygous T allele at FCGR2 Arg131His as compared with Whites and Africans. Ethnic variation of FCGR2 may explain why certain diseases vary between ethnic populations, but this needs further study [Yuan and Sullivan, 2005] .
Genetic studies of mycobacterial disease Mycobacterium tuberculosis (MTB) causes tuberculosis (TB) and is a major cause of illness and deaths, but some individuals never develop disease despite a lifetime spent in regions of Asia and Africa where the infection is endemic. Similarly it is likely that everyone in the world is exposed to nontuberculous mycobacteria (NTM; Mycobacterium kansasii and Mycobacterium avium-intracellulare) but most people never display signs or symptoms of infection. In countries where molecular diagnosis of chronic infections is standard practice, children with defined genetic defects are severely affected by NTM [Remus et al. 2001 ] and some people, notably older ladies with no identifiable risk factor, experience chronic pulmonary NTM disease . Subtle changes in immune responses may confer an increased risk in the context of normal age-associated changes in immunocompetence.
NTM disease and TB are more common and severe in patients coinfected with HIV. In addition, immune reconstitution on antiretroviral therapy (ART) invokes an exacerbation of symptoms in a subset of patients (immune restoration disease [IRD]) [Price et al. 2009 ]. Susceptibility may reflect factors that influence mycobacterial disease in patients without HIV, as well as genetic determinants of HIV-associated immune dysfunction.
Clearance of mycobacteria requires an effective cell-mediated immune response [Hill, 1998] . Interleukin (IL)-12 drives production of interferon gamma (IFNg) from natural killer (NK) cells and antigen-specific Th1 cells. The activation of infected macrophages by IFNg, in synergy 
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with TNFa, is a major effector mechanism. In resting macrophages, mycobacteria reside within modified phagosomes that intersect with the host cell's recycling endosomal network, actively blocking encounters with lysosomes. Activation removes the block in lysosome fusion and exposes bacteria to a proton-rich lysosome, where hydrolases, reactive nitrogen intermediates and reactive oxygen intermediates kill replicating bacteria. Clearance of all cells harbouring latent infections is mediated by cytolytic CD8 T cells. This is also promoted by Th1 cytokines. The importance of TNF is illustrated by evidence that TNF inhibitors administered as therapy for Crohn's disease or rheumatoid arthritis promote TB [Desai and Furst, 2006 ]. All aspects of this pathway reflect candidate genes with potential to affect the outcome of mycobacterial infection.
Tuberculosis
Host genotype is likely to be an important determinant of susceptibility to TB, because monozygotic twins have a higher concordance than dizygotic twins [Comstock, 1978] . The infection is airborne and endemic in many countries. Treatment is protracted and relapse is common. The World Health Organization is extending treatment and prevention strategies with a goal of halving 1990 prevalence and death rates by 2015. Despite impressive progress in many countries, this goal is unlikely to be met for the world as a whole. Several recombinant vaccines are now being trialled [Scriba et al. 2010 ], but their evaluation requires an understanding of the immune mechanisms critical for protection. Genetic studies can reveal the relative importance of immunological pathways identified in animal studies.
Published associations are summarized in Cluster of differentiation 14 (CD14) is involved in the recognition of lipopolysaccharides (LPS) and bacterial cell wall components by macrophages CD14 C-159T (C/T) (rs2569190) Homozygous allele 2 associated with TB in Mexicans [Rosas-Taraco et al. 2007] No association with pulmonary TB in Colombians [Pacheco et al. 2004] Tumour necrosis factor and IL-1 mediate fever and inflammation associated with TB TNFA-308 (G/A)
TNFA þ 488 (G/A) No association with TB in South Indian, Korean, Thai or Turkish patients (Note: HLA associations with TNF alleles show ethnic variation) [Ates et al. 2008; Oh et al. 2007; Vejbaesya et al. 2007; Selvaraj et al. 2001] TNFA-308 (G/A)
TNF-238 (G/A) (rs361525) TNF-308 allele 1 associated with TB, whilst allele 2 associated with several autoimmune diseases in Colombians TNF-238 (allele 2 was protective for autoimmunity but associated with susceptibility for TB)
The haplotype TNF-308*2-238*1 was protective against TB but carried susceptibility for autoimmune diseases [Correa et al. 2005] TNFA-308 (G/A)
TNF-1031 (T/C) [Prabhu Anand et al. 2007] No association with susceptibility to TB, but homozygous allele 2 linked with increased levels of IL-12p40 (South Indian) [Selvaraj et al. 2008b] Carriage of allele 2 associated with TB in Hong Kong Chinese [Tso et al. 2004] No association with TB (African American and whites) [Ma et al. 2003] Therapeutic Advances in Respiratory Disease 4 (3)
IL12RB1 À2
(C/T) Carriage of allele 2 associated with TB in Moroccans [Remus et al. 2004] No association with pulmonary TB in Indonesians [Sahiratmadja et al. 2007] IL12RB1 þ467
G/A The 214*2-365*2-378*2 haplotype associated with susceptibility to TB in Japanese patients [Akahoshi et al. 2003] Carriage of allele 2 of the þ641, þ1094
and 1132 SNPs associated with pulmonary TB susceptibility and severity in Japanese patients [Kusuhara et al. 2007] The þ705, þ1158, þ1196, þ1637
and þ1664 [Leung et al. 2007] Heterozygosity associated with severe forms of pulmonary TB but not susceptibility to TB in Chinese [Zhang et al. 2005] Carriage of allele 2 associated with TB in Gambian, Japanese and Cambodian cohorts [Delgado et al. 2002; Gao et al. 2000; Bellamy et al. 1998b] Homozygous allele 2 associated with susceptibility to pulmonary TB in a Chinese Han cohort [Liu et al. 2004] NRAMP1 3 0 UTR (TGTGþ/ deletion) Carriage of allele 2 associated with tuberculous pleurisy in Koreans [Kim et al. 2003b] Not associated with microscopy-positive TB in a Danish cohort [Soborg et al. 2002] Heterozygosity associated with susceptibility to pulmonary TB in a Chinese Han cohort [Liu et al. 2004] NRAMP1 INT4 (G/C) Heterozygosity associated with susceptibility to TB in Gambians [Bellamy et al. 1998b] Heterozygosity associated with severe forms of pulmonary TB but not susceptibility to TB in Chinese patients [Zhang et al. 2005] Heterozygosity associated with increased mycobacterial replication rather than susceptibility to TB, thus increasing risk of severe disease in a Danish cohort [Zhang et al. 2005; Kim et al. 2003a; Soborg et al. 2002] Carriage of allele 2 associated with tuberculous pleurisy in Koreans [Kim et al. 2003a] NRAMP1 5 0 (CA)n -allele 1 (199bp) -allele 2 (201bp) -allele 3 (203bp) Carriage of allele 2 or 3 associated with increased mycobacterial replication rather than susceptibility to TB, thus increasing risk of severe disease in a Danish cohort [Zhang et al. 2005; Kim et al. 2003a; Soborg et al. 2002] Carriage of allele 2 or 3 is associated with TB in Gambians [Bellamy et al. 1998b] Carriage of allele 3 associated with resistance to TB [Gao et al. 2000] Notation of alleles is gene-nucleotide position (allele 1/allele 2), with allele 1 being the most frequent in the population (wild-type). Amino acid changes are presented where they arise.
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TB patient may also present as prolonged, high-grade fever.
We assembled a cohort of IRD patients for studies of immunological and genetic determinants of disease. HLA-B44 and the haplotype HLA-A2, B44, TNFA-308 Ã A, BAT1(intron10) Ã C, DR4 were more common in patients who experienced an IRD manifested as CMV retinitis and/or encephalomyelitis than controls [Price et al. 2001] .
Patients with IRD arising from mycobacterial lymphadenitis rarely carried IL6-174*C (rs1800795, 36% versus 6171%) and never carried TNFA-308 Ã A (rs1800629, 0% versus 2352%) [Price et al. 2002] . The study established that distinct cytokine-mediated mechanisms contribute to IRD initiated by herpes viruses and mycobacterial infections. No genetic studies of IRD associated with TB have been published. However, in a pilot study using a Cambodian cohort, TNFA-1031 Ã C (rs1799964) was carried at the same frequency in HIV þ TB þ and HIV þ TB À patients, so the allele did not mark susceptibility to TB in an HIV patient. However, TNFA-1031 Ã C was slightly more common in TBþ patients who experienced an IRD compared with HIV þ TB þ (p ¼ 0.08, odds ratio [OR] ¼ 3.41) or HIV þ TB À (p ¼ 0.05, OR ¼ 3.45) controls, so the allele may mark increased susceptibility to an IRD event [Affandi et al. 2009 ].
In conclusion, genetic studies of TB must take the ethnicity of the patients into consideration. Indeed TB (þ/À HIV) is rare in Whites in the developed world. Studies of cytokine haplotypes in African and Asian populations will be critical, such as those described in the following section for TNF.
A review of candidate SNPs likely to affect respiratory disease Immune-related genes are considered in a sequence reflecting the host response to infection; specifically the recognition of the pathogen by host cells, the signals induced, the acute inflammatory response and the development of protective immunity. Associations with individual polymorphisms are summarized in Tables 1, 2 and 3.
Pattern recognition molecules
Eleven toll-like receptors (TLRs) have been identified in humans, with affinities for motifs characteristic of different micro-organisms. The most important here are TLR2, which interacts with lipopeptides, peptidoglycan and lipotechoid acid from the cell walls of Gram-positive bacteria, and TLR4, which interacts with the Gram-negative endotoxin, lipopolysaccharides (LPS), and pneumococcal pneumolysin [Beutler, 2002] . Homozygosity at allele 2 of TLR2-16934 (T/A) may increase the risk of Gram-positive infections including pneumonia [Sutherland et al. 2005 ]. Carriage of allele 2 in TLR2 Arg677Trp (C/T, rs5743706) and TLR2 Arg753Gln (G/A, rs5743708) may be associated with mycobacterial infections, TB and leprosy [Ben-Ali et al. 2004; Kang and Chae, 2001] . Carriage of allele 2 in TLR4 Asp299Gly (A/G, rs4986790) and TLR4 Thr399Ile (C/T, rs4986791) has been correlated with Gram-negative sepsis [Yuan et al. 2008; Lorenz et al. 2002] . However, other studies did not confirm these results [Everett et al. 2007; Yoon et al. 2006 ]. Carriage of allele 2 in TLR5 Arg392 Stopcodon [1174, (C/T)], TLR5 Asn592Ser [1175, (A/G)], TLR5 1174 Ã T-1175 Ã A and TLR5 1174 Ã C-1175 Ã G were associated with an Table 3 . Associations/dissociations of single nucleotide polymorphisms (SNPs) in immune-related genes and adult nontuberculous mycobacteria (NTM) disease.
SNP
Association with mycobacterial disease Reference TLR2 is critical for the recognition of mycobacteria by antigen presenting cells (APC) TLR2 Arg677Trp (C/T)
Minor alleles were not present in Koreans Ryu et al. 2006] TLR2 Arg753Gln (G/A) (rs5743708)
NRAMP1 encodes a divalent cation transporter which removes Fe 2þ from phagosomes NRAMP1 D543N (G/A)
Heterozygosity associated with NTM lung disease (NTMLD) in Korean and Japanese cohorts [Tanaka et al. 2007; Koh et al. 2005 
Notation of alleles is gene-nucleotide position (allele 1/allele 2), with allele 1 being the most frequent in the population (wild-type). Amino acid changes are presented where they arise.
increased risk of Legionella pneumophila infection [Hawn et al. 2003 ].
Surfactant proteins have an antigen recognition function through interaction with TLR2 and TLR4. Low levels of pulmonary surfactant proteins are associated with increased risk of pneumonia [Griese et al. 2008] . A polymorphism in surfactant protein B, SP-B þ1580 (T/C) was associated with increased risk of pneumonia in one cohort study [Quasney et al. 2004 ], but no further studies have been reported.
Signalling pathways
Myeloid differentiation factor 88 (MyD88) adapter-like protein (MAL; also known as TIRAP) mediates downstream signalling of TLR2 and TLR4 [Beutler, 2002] . A leucine substitution at Ser180 of MAL was associated with decreased susceptibility to infectious diseases in general and specifically to pneumococcal disease [Khor et al. 2007 ]. Polymorphisms in Ikappa-beta-alpha [Chapman et al. 2007] and Ikappa-beta-zeta [Chapman et al. 2009] were described as risk factors for invasive pneumococcal disease by the same group. A single report of nuclear factor-kappaB (NF-kB) essential modulator (NEMO) and IRAK-4 polymorphisms suggests these may be a risk factor for pneumococcal disease, at least in children [Ku et al. 2007 ].
Pro-inflammatory cytokines
TNF is an important pro-inflammatory cytokine and a key initial component of the inflammatory response. There is a considerable inherited variability in the TNF gene and potential for the protein to influence pneumonia and sepsis. However it lies in a highly polymorphic region of the major histocompatability complex (MHC) on chromosome 6, making LD a major problem to be addressed.
The A allele at TNFA-308 has been associated with an increased risk of death from a variety of infectious diseases, including melioidosis [Nuntayanuwat et al. 1999] . However several studies found no association between TNFA-308 and susceptibility or outcome of CAP [Sole-Violan et al., 2009; Kinder et al. 2007; Waterer et al. 2001b] . A two-SNP haplotype including TNFA-308 Ã A and TNFA-238 Ã A (rs361525) may be a better predictor of higher mortality in sepsis [Henckaerts et al. 2009; Pappachan et al. 2009 ] and at least one study found TNFA-238 allele A predicted increased risk of adverse outcome from pneumonia [Kinder et al. 2007 LTA is adjacent to TNF on chromosome 6 and carriage of the A allele at LTAþ252 (G/A, rs909253) was one of the first genetic factors associated with death from septic shock [Stuber et al. 1996] . Subsequent studies demonstrated that the patients who are homozygous for allele A in LTAþ252 was also an indicator for the development of sepsis in trauma patients [Majetschak et al. 1999] and in patients with pneumonia [Waterer et al. 2001a ] although other studies have not found this association [Henckaerts et al. 2009; Sole-Violan et al. 2009 ]. Associations with LTAþ252 may reflect linked polymorphisms in the gene encoding heat shock protein-70. The candidate HSPA1B-179 (C/T, rs6457452) is in linkage with HSPA1B-1267 (A/G, rs1061581) and is associated with lower HSP-70 expression at baseline, higher TNF production after exposure to bacteria and an increased risk of septic shock. This fits current models of the pathogenesis of sepsis [Temple et al. 2004; Waterer et al. 2003 ].
The region spanning the TNF cluster has been implicated in susceptibility to numerous immunopathological diseases [Allcock et al. 2004] , as well as CAP [Waterer et al. 2001b ], but strong LD has hampered identification of polymorphisms responsible for the disease phenotypes. We investigated European, Asian and Australian Aboriginal populations to provide a framework for disease association studies using DNA from 999 unrelated healthy donors genotyped at 38 loci over a 60 kb region spanning seven genes near TNF. The PHASE algorithm was used to statistically infer TNF block haplotypes and estimate their frequencies in each population. We found just 31 haplotypes in all populations combined, with less than 19 in any single population. Four to eight TNF block haplotypes exist across all ethnicities and hence must predate the divergence of these populations from a common ancestor, possibly >160,000 years ago. Some haplotypes are unique to isolated populations but they do not contain unique SNPs [Valente et al. 2009 ]. Hence, they reflect restricted migration and/or extinction of some families rather than de-novo mutation. We are now examining these haplotypes in patients with HIV-associated TB and NTM infections.
Macrophage migration inhibition factor (MIF) is released by monocytes and macrophages and exerts potent pro-inflammatory activities [Calandra and Roger, 2003] . Clinical studies associate higher circulating MIF levels with severity and susceptibility of sepsis [Gao et al. 2007] . A study of 1729 patients with CAP found 90-day mortality was lower for patients carrying the high-expression C allele of MIF-173 (G/C, rs755622) [Yende et al. 2009 ].
Anti-inflammatory responses
Three promoter polymorphisms in the IL10 gene [À1082 (rs1800896)/À819 (rs1800871)/À592 (rs1800872)] have been studied extensively and different À819/À592 haplotypes are associated with variable IL-10 production [Turner et al. 1997 ]. The effects of the IL10 haplotype may depend on whether the stimulus is Gram positive or Gram negative [Temple et al. 2003 ]. Several casecontrol studies suggest that the IL10-1082 G allele is a significant risk factor for adverse outcome in patients with pneumonia [Gallagher et al. 2003; Schaaf et al. 2003 ]. Somewhat confusingly the IL10 haplotype À592C/734G/3367G was associated with increased mortality in patients with pulmonary sepsis, but not in similarly ill patients with extrapulmonary sepsis [Wattanathum et al. 2005 ]. This may reflect LD between IL10 and FCGR2 polymorphisms, as discussed earlier.
Pathways activated by inflammation
Activation of the coagulation system may influence multiorgan dysfunction in sepsis [Bastarache et al. 2006 ]. For example, mice heterozygous for factor V Leiden status have improved survival after exposure to LPS [Weiler et al. 2004 ] and the efficacy of activated protein C was greater in sepsis patients carrying the factor V Leiden mutation [Yan and Nelson, 2004] . A prospective cohort study in 3347 patients with pneumonia associated a promoter haplotype (Plasminogen activator inhibitor-1, PAI 4G/ 2846G/4588C/7343A) with increased susceptibility to pneumonia, with PAI-1 levels after stimulation 20% higher in subjects with a 4G genotype as compared with those with 5G [Yende et al. 2007] . A further study found an association with mortality and carriage of the 4G allele of PAI-1 [Sapru et al. 2009 ], but other polymorphisms were not assessed so it is not clear whether this reflects the same haplotype.
Understanding genetic associations:
Caveat emptor Genetic studies have appeal to clinical researchers because the time of sample collection is flexible, DNA samples are robust and the assays are easily automated. Finding a sensitive and specific test of susceptibility or a novel pathogenic pathway has appeal. However, many SNPs do not associate with disease, so it is important to emphasize that we conclude nothing from null associations. A positive association places the gene (or one in LD) somewhere in the path to disease, but LD precludes assumptions about role of the SNP. A null association will occur if the SNP (and its haplotype) do not affect gene expression, or if expression is not limiting in the disease process (so it does not matter if it varies). The reports reviewed herein show that effective genetic studies require detailed interpretation of the associated haplotypes with consideration to ethnic background and confounding factors. Barreiro, L.B., Neyrolles, O., Babb, C.L., Tailleux, L., Quach, H., McElreavey, K. et al. (2006) 
